Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

649
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
649
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

650
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
650
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

575
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
575
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

712
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
712
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

329
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
329
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.0K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous mark-release recapture to improve estimates of movement and survival of the African malaria mosquitoes.

bioRxiv : the preprint server for biology·2026
Same author

A multifaceted disease.

Acta gastro-enterologica Belgica·2025
Same author

Distribution of epithelial endoplasmic reticulum stress-related proteins in adult and pediatric Crohn's disease: Association with inflammation and fibrosis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Pathogens spread by high-altitude windborne mosquitoes.

bioRxiv : the preprint server for biology·2025
Same author

Evaluation of the adherence of patients with chronic inflammatory bowel diseases to a PRO telemonitoring using connected devices: a prospective monocentric study.

Acta gastro-enterologica Belgica·2025
Same author

Interconnection between adolescents' and family members' sleep.

Scientific reports·2024

Related Experiment Video

Updated: Dec 1, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

536

[Increased neoplastic risks in ulcerative colitis associated with primary sclerosing cholangitis].

C Kouam1, O Warling1, C Van Kemseke1

  • 1Service d'Hépato-Gastroentérologie et d'Oncologie digestive, CHU Liège, Belgique.

Revue Medicale De Liege
|November 6, 2020
PubMed
Summary

Ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) share a complex link, particularly in BRCA1 mutation carriers. This case highlights the potential for gallbladder cancer in patients with UC and PSC.

Keywords:
BRCA1CholangiocarcinomaCholangioscopyColorectal cancerGallbladderPrimary sclerosing cholangitisUlcerative colitis

More Related Videos

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.4K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.6K

Related Experiment Videos

Last Updated: Dec 1, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

536
Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
08:51

Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch

Published on: August 24, 2019

10.4K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.6K

Area of Science:

  • Gastroenterology and Hepatology
  • Oncology
  • Genetics

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease with potential extraintestinal manifestations.
  • Primary sclerosing cholangitis (PSC) is a chronic liver disease often associated with inflammatory bowel disease.
  • BRCA1 gene mutations are linked to various cancers and may influence inflammatory conditions.

Observation:

  • A patient with a BRCA1 mutation presented with abdominal pain and bloody diarrhea, indicative of UC.
  • Biliary tract stenosis was incidentally discovered, leading to a suspicion of PSC or cholangiocarcinoma (CCA).
  • Gallbladder cancer was diagnosed during the management of presumed UC and PSC.

Findings:

  • The clinical presentation suggests a strong association between UC, PSC, and potentially CCA in a BRCA1 mutation carrier.
  • The case underscores the multisystemic nature of UC and its hepatic manifestations.
  • The development of gallbladder cancer adds another layer of complexity to the patient's condition.

Implications:

  • This case emphasizes the importance of investigating hepatic manifestations in patients with UC, especially those with genetic predispositions like BRCA1 mutations.
  • Understanding the pathophysiological link between UC and PSC is crucial for early diagnosis and management of associated cancers.
  • The findings necessitate a review of current management strategies for UC and PSC, considering their malignant potential and genetic associations.